Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Immupharma (IMM) Share News

ImmuPharma Exploring European Listing For Combined French Businesses (ALLIPO)

7th May 2019 11:06

LONDON (Alliance News) - ImmuPharma PLC is exploring the merger and possible separate listing of two French subsidiaries, it said Tuesday.Elro Pharma Sarl and Ureka Sarl are currently on a Read More

ImmuPharma Loses Exclusivity Period For Talks With Incanthera

1st Apr 2019 14:07

LONDON (Alliance News) - ImmuPharma PLC on Monday said proposed partner Incanthera Ltd can now talk with other potential parties after an exclusivity period ended.In September, ImmuPharma a Read More

ImmuPharma Preparing For Lupuzor Drug Managed Access Programme

14th Mar 2019 10:41

LONDON (Alliance News) - ImmuPharma PLC said it is in final preparations to open a managed access programme for its lupus drug Lupuzor to patients in Europe.Shares in the drug discovery and Read More

ImmuPharma Progressing To Make Lupuzor Available To Patients

7th Dec 2018 11:26

LONDON (Alliance News) - ImmuPharma PLC on Friday said it is currently in the process of making Lupuzor, its drug for the treatment of lupus, available to patients via its managed access drug said Read More

ImmuPharma Interim Loss Widens On Higher Costs And Lower Revenue

26th Sep 2018 12:40

LONDON (Alliance News) - ImmuPharma PLC said on Wednesday it continues to progress its lupus treatment Lupuzor, as it saw a widened loss for the first half of 2018 due to higher costs and lower a Read More

ImmuPharma Inks Pact With Incanthera For Nucant Cancer Programme

7th Sep 2018 11:43

LONDON (Alliance News) - ImmuPharma PLC said Friday it signed a clinical development collaboration for the Nucant cancer programme with Incanthera Ltd, a specialist oncology development the terms Read More

Immupharma Says P140 Peptide Shows Positive Results In CIDP Treatment

14th Jun 2018 12:02

LONDON (Alliance News) - ImmuPharma PLC said Thursday that its pre-clinical studies of the P140 peptide showed positive results in the treatment of chronic inflammatory demyelinating were trading Read More

ImmuPharma Excited Despite Widened Loss As Lupuzor Makes Good Results

29th May 2018 09:40

LONDON (Alliance News) - ImmuPharma PLC said Tuesday it continues to be "excited" by its future potential despite a widened loss for 2017.The drug development company reported a a Read More

ImmuPharma Prepares To Report Lupuzor Study Results In April

23rd Mar 2018 11:17

LONDON (Alliance News) - Drug development company ImmuPharma PLC said on Friday it has been informed by Simbec-Orion that the data-base lock for the Lupuzor pivotal phase III Read More